Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
TFF1
REST API REST API
Homo sapiens
TFF1 is differentially expressed in 179 experiments: 74 organism parts: prostate, trachea, ... (72 more);, 65 disease states: normal, gastric carcinoma, ... (63 more);, 39 cell types 290 cell lines 22 compound treatments and 58 other conditions.
Synonyms pS2, BCEI, pNR-2, HPS2, HP1.A, D21S21
Orthologs Tff1 (Mus musculus)   ENSGALG00000016165 (Gallus gallus)   Gm3090 (Mus musculus)   Tff1 (Rattus norvegicus)   tff2 (Xenopus laevis)   TFF1 (Bos taurus)   TFF1_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term digestion, extracellular space, growth factor activity, response to stress, extracellular region, carbohydrate metabolic process, maintenance of gastrointestinal epithelium, response to iron ion, response to peptide hormone stimulus, response to estradiol stimulus
InterPro Term P_trefoil, P_trefoil_chordata
UniProt Accession P04155
Search EB-eye ENSG00000160182
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-MTAB-24, E-MTAB-25, ... (19 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-19397, ... (29 experiments)

Factor Value U/D Experiments
BT474
3
E-MTAB-37, E-MEXP-440, E-MTAB-62
SW480
3
E-MEXP-1014, E-GEOD-18005, E-MTAB-37
MCF-7
1
3
E-GEOD-20081, E-GEOD-5823, E-GEOD-3529, E-GEOD-19639
A549
2
E-GEOD-6013, E-GEOD-3202
H2126
2
E-MTAB-62, E-GEOD-4342
MCF7
2
E-GEOD-5258, E-MTAB-37
284 more value(s).


Cell type

studied in E-GEOD-15893, E-GEOD-18811, E-AFMX-5, E-GEOD-22373, E-MTAB-24, ... (23 experiments)

Factor Value U/D Experiments
macrophage
2
E-GEOD-22373, E-GEOD-8286
testis - leydig cell
1
E-AFMX-5
CD56+ NK cells
1
E-AFMX-5
secretory cell
1
E-GEOD-3998
Monocytes
1
E-GEOD-21909
embryonic stem cell
1
E-MEXP-930
33 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-TABM-15, E-GEOD-5370, E-MTAB-62, ... (27 experiments)

Factor Value U/D Experiments
gastric carcinoma
3
E-MTAB-37, E-GEOD-2685, E-GEOD-15460
benign nevus
1
E-GEOD-3189
lung large cell carcinoma
1
E-MTAB-62
lung atypical carcinoid tumor
1
E-MTAB-37
Barrett's esophagus
1
E-GEOD-1420
cancerous
1
E-TABM-15
59 more value(s).


Compound treatment

studied in E-GEOD-4668, E-GEOD-6907, E-GEOD-15205, E-GEOD-6462, E-MEXP-2590, ... (15 experiments)

Factor Value U/D Experiments
TGF
1
E-GEOD-15205
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
hydroxyurea
1
E-GEOD-6431
mercury dichloride
1
E-GEOD-6907
unknown
1
E-GEOD-7307
NaOH
1
E-MEXP-2590
16 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-GEOD-19743, E-GEOD-21374, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-2034, E-GEOD-21589, ... (7 experiments)

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-1614, E-MTAB-62

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-TABM-147, E-GEOD-21138, E-GEOD-3013 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643

Er
studied in E-GEOD-20194, E-GEOD-16716

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-4922, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-6431

Genotype
studied in E-MEXP-1996, E-GEOD-1045, E-GEOD-3494, E-MEXP-421, E-GEOD-22593, ... (10 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-20540, E-GEOD-20504, E-MEXP-1446, E-GEOD-10315 ... (5 experiments)

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-276

Individual
studied in E-TABM-325, E-GEOD-5764, E-GEOD-1926, E-GEOD-16363, E-GEOD-430, ... (27 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-980

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Material type
studied in E-MEXP-455, E-MEXP-958

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Pcr vs rd
studied in E-GEOD-20194, E-GEOD-16716

Phenotype
studied in E-GEOD-1309

Pr ihc
studied in E-GEOD-21653

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-22097, E-GEOD-21837, E-GEOD-19445

Replicate
studied in E-GEOD-10797

RNAi
studied in E-GEOD-12438, E-GEOD-3697

Sample preparation
studied in E-GEOD-16728

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-7307

Strain or line
studied in E-MEXP-1996

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-15799

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-89, E-TABM-43, E-GEOD-1561, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.338 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM